206 related articles for article (PubMed ID: 25403959)
1. Ductal carcinoma in situ: a brief review of treatment variation and impacts on patients and society.
Vatovec C; Erten MZ; Kolodinsky J; Brown P; Wood M; James T; Sprague BL
Crit Rev Eukaryot Gene Expr; 2014; 24(4):281-6. PubMed ID: 25403959
[TBL] [Abstract][Full Text] [Related]
2. Standard for the management of ductal carcinoma in situ of the breast (DCIS).
Morrow M; Strom EA; Bassett LW; Dershaw DD; Fowble B; Harris Ja; O'Malley F; Schnitt SJ; Singletary SE; Winchester DP; ; ; ;
CA Cancer J Clin; 2002; 52(5):256-76. PubMed ID: 12363325
[TBL] [Abstract][Full Text] [Related]
3. Avoiding Overtreatment of Ductal Carcinoma in situ.
van der Borden CL; Stoffers S; Lips EH; Wesseling J
Trends Cancer; 2019 Jul; 5(7):391-393. PubMed ID: 31311652
[TBL] [Abstract][Full Text] [Related]
4. Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS).
Groen EJ; Elshof LE; Visser LL; Rutgers EJT; Winter-Warnars HAO; Lips EH; Wesseling J
Breast; 2017 Feb; 31():274-283. PubMed ID: 27671693
[TBL] [Abstract][Full Text] [Related]
5. Ductal carcinoma in situ: to treat or not to treat, that is the question.
van Seijen M; Lips EH; Thompson AM; Nik-Zainal S; Futreal A; Hwang ES; Verschuur E; Lane J; Jonkers J; Rea DW; Wesseling J;
Br J Cancer; 2019 Aug; 121(4):285-292. PubMed ID: 31285590
[TBL] [Abstract][Full Text] [Related]
6. How different terminology for ductal carcinoma in situ (DCIS) impacts women's concern and management preferences: A qualitative study.
Nickel B; Barratt A; Hersch J; Moynihan R; Irwig L; McCaffery K
Breast; 2015 Oct; 24(5):673-9. PubMed ID: 26376460
[TBL] [Abstract][Full Text] [Related]
7. Reflex Estrogen Receptor (ER) and Progesterone Receptor (PR) Analysis of Ductal Carcinoma In Situ (DCIS) in Breast Needle Core Biopsy Specimens: An Unnecessary Exercise That Costs the United States $35 Million/y.
VandenBussche CJ; Cimino-Mathews A; Park BH; Emens LA; Tsangaris TN; Argani P
Am J Surg Pathol; 2016 Aug; 40(8):1090-9. PubMed ID: 27299796
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of the Less Is More Approach in Treating Low-Risk Ductal Carcinoma In Situ Diagnosed on Core Needle Biopsy: Ten-Year Review of Ductal Carcinoma In Situ Upgraded to Invasion at Surgery.
Podoll MB; Reisenbichler ES; Roland L; Bruner A; Mizuguchi S; Sanders MAG
Arch Pathol Lab Med; 2018 Sep; 142(9):1120-1126. PubMed ID: 29582675
[TBL] [Abstract][Full Text] [Related]
9. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
Sakorafas GH; Tsiotou AG
Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
[TBL] [Abstract][Full Text] [Related]
10. How different terminology for ductal carcinoma in situ impacts women's concern and treatment preferences: a randomised comparison within a national community survey.
McCaffery K; Nickel B; Moynihan R; Hersch J; Teixeira-Pinto A; Irwig L; Barratt A
BMJ Open; 2015 Nov; 5(11):e008094. PubMed ID: 26525720
[TBL] [Abstract][Full Text] [Related]
11. Addressing overtreatment of screen detected DCIS; the LORIS trial.
Francis A; Thomas J; Fallowfield L; Wallis M; Bartlett JM; Brookes C; Roberts T; Pirrie S; Gaunt C; Young J; Billingham L; Dodwell D; Hanby A; Pinder SE; Evans A; Reed M; Jenkins V; Matthews L; Wilcox M; Fairbrother P; Bowden S; Rea D
Eur J Cancer; 2015 Nov; 51(16):2296-303. PubMed ID: 26296293
[TBL] [Abstract][Full Text] [Related]
12. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
13. Current approach and future perspective for ductal carcinoma in situ of the breast.
Kanbayashi C; Iwata H
Jpn J Clin Oncol; 2017 Aug; 47(8):671-677. PubMed ID: 28486668
[TBL] [Abstract][Full Text] [Related]
14. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
15. Ductal carcinoma in situ: a disease entity that merits more recognition.
Dereere E; Papadimitriou K; Tjalma W; Altintas S
Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
[TBL] [Abstract][Full Text] [Related]
16. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience.
Fisher B; Land S; Mamounas E; Dignam J; Fisher ER; Wolmark N
Semin Oncol; 2001 Aug; 28(4):400-18. PubMed ID: 11498833
[TBL] [Abstract][Full Text] [Related]
17. Current Therapeutic Approaches to DCIS.
Doke K; Butler S; Mitchell MP
J Mammary Gland Biol Neoplasia; 2018 Dec; 23(4):279-291. PubMed ID: 30267199
[TBL] [Abstract][Full Text] [Related]
18. Views of healthcare professionals about the role of active monitoring in the management of ductal carcinoma in situ (DCIS): Qualitative interview study.
Nickel B; McCaffery K; Houssami N; Jansen J; Saunders C; Spillane A; Rutherford C; Dixon A; Barratt A; Stuart K; Robertson G; Hersch J
Breast; 2020 Dec; 54():99-105. PubMed ID: 32971350
[TBL] [Abstract][Full Text] [Related]
19. Ductal carcinoma in situ of the breast: diagnosis and management.
Friedrich M; Felberbaum R; Krämer S; Axt-Fliedner R; Diedrich K
Onkologie; 2003 Dec; 26(6):588-95. PubMed ID: 14709936
[TBL] [Abstract][Full Text] [Related]
20. Standard for breast conservation therapy in the management of invasive breast carcinoma.
Morrow M; Strom EA; Bassett LW; Dershaw DD; Fowble B; Giuliano A; Harris JR; O'Malley F; Schnitt SJ; Singletary SE; Winchester DP; ; ; ;
CA Cancer J Clin; 2002; 52(5):277-300. PubMed ID: 12363326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
